Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01185275 · ClinicalTrials.gov registry record
A Prospective Observational Study of Biopredictors of Bronchial Thermoplasty Response in Patients With Severe Refractory Asthma (BTR Study)
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 133
- Enrollment target
NCT01185275 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 133 participants.
The verdict
NCT01185275 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 133 participants
- Enrollment target
Study Summary
Clinical response, as defined by improvement in asthma quality of life, to bronchial thermoplasty in patients with severe refractory asthma can be predicted through the use of clinical, physiologic, biologic and imaging markers.
Interventions
- DEVICE Alair system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2010-08 |
| Est. Completion | 2019-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01185275
The ClinicalTrials.gov registry entry for NCT01185275 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alair system is the first listed.
NCT01185275 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01185275 about?
NCT01185275 is a clinical study titled "A Prospective Observational Study of Biopredictors of Bronchial Thermoplasty Response in Patients With Severe Refractory Asthma (BTR Study)". Clinical response, as defined by improvement in asthma quality of life, to bronchial thermoplasty in patients with severe refractory asthma can be predicted through the use of clinical, physiologic, biologic and imaging markers.
What is the current status of trial NCT01185275?
This trial is currently completed. The enrollment target is 133 participants. The study started on 2010-08. Estimated completion is 2019-10-01.
What interventions are being tested in trial NCT01185275?
The interventions under investigation include: Alair system (DEVICE).
Who is sponsoring clinical trial NCT01185275?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.